GR3034853T3 - Oxidized oligosaccharides - Google Patents

Oxidized oligosaccharides

Info

Publication number
GR3034853T3
GR3034853T3 GR20000402542T GR20000402542T GR3034853T3 GR 3034853 T3 GR3034853 T3 GR 3034853T3 GR 20000402542 T GR20000402542 T GR 20000402542T GR 20000402542 T GR20000402542 T GR 20000402542T GR 3034853 T3 GR3034853 T3 GR 3034853T3
Authority
GR
Greece
Prior art keywords
oligosaccharides
oxidized
oxidized oligosaccharides
orc
proteins
Prior art date
Application number
GR20000402542T
Other languages
English (en)
Inventor
Wilson Harvey
Lowell Saferstein
David Wiseman
Paul William Watt
Nicholas Light
Original Assignee
Johnson & Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd
Publication of GR3034853T3 publication Critical patent/GR3034853T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C08B15/04—Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G3/00—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicinal Preparation (AREA)
GR20000402542T 1996-06-28 2000-11-15 Oxidized oligosaccharides GR3034853T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9613683A GB2314840B (en) 1996-06-28 1996-06-28 Oxidized oligosaccharides and pharmaceutical compositions
PCT/GB1997/001726 WO1998000446A1 (en) 1996-06-28 1997-06-27 Oxidized oligosaccharides

Publications (1)

Publication Number Publication Date
GR3034853T3 true GR3034853T3 (en) 2001-02-28

Family

ID=10796095

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402542T GR3034853T3 (en) 1996-06-28 2000-11-15 Oxidized oligosaccharides

Country Status (16)

Country Link
EP (1) EP0907664B1 (el)
JP (2) JP4302187B2 (el)
KR (1) KR20000022286A (el)
AT (1) ATE195742T1 (el)
AU (1) AU725296B2 (el)
BR (1) BR9710003A (el)
CA (1) CA2258849C (el)
CZ (1) CZ294839B6 (el)
DE (1) DE69702911T2 (el)
ES (1) ES2148991T3 (el)
GB (1) GB2314840B (el)
GR (1) GR3034853T3 (el)
HU (1) HUP9903404A3 (el)
PL (1) PL189194B1 (el)
PT (1) PT907664E (el)
WO (1) WO1998000446A1 (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
GB9900150D0 (en) 1999-01-05 1999-02-24 Unilever Plc Treatment for fabrics
GB2354708B (en) * 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
AU782756B2 (en) * 2000-05-12 2005-08-25 Systagenix Wound Management Ip Co. B.V. Solid composition exhibiting selective binding to dissolved iron
AU784607B2 (en) * 2000-05-12 2006-05-11 Systagenix Wound Management Ip Co. B.V. Free radical scavenging compositions
CN100398159C (zh) * 2001-04-30 2008-07-02 北京纺织科学研究所 水溶性纤维素醚化衍生物止血材料
US20030118651A1 (en) * 2001-12-21 2003-06-26 Jampani Hanuman B. Bio-compatible means for controlled drug delivery to tissue and method of use
US20030124087A1 (en) * 2001-12-26 2003-07-03 Amitie Co. Ltd. Anti-adhesion barrier
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
US7279177B2 (en) * 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
PT1536845E (pt) 2002-09-11 2007-06-01 Johnson & Johnson Medical Ltd Materiais de penso compreendendo complexos de polissacarídeos aniónicos com prata
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US8685943B2 (en) 2003-03-12 2014-04-01 Hill's Pet Nutrition, Inc. Methods for reducing diarrhea in a companion animal
US7019191B2 (en) 2003-03-25 2006-03-28 Ethicon, Inc. Hemostatic wound dressings and methods of making same
DE10319808A1 (de) * 2003-04-28 2004-11-18 Friedrich-Schiller-Universität Jena Verwendung von Polysaccharid-Derivaten als Mittel zur Stimulierung der Zellproliferation
GB2408206B (en) 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
EP1689787A2 (en) 2003-11-28 2006-08-16 Eastman Chemical Company Cellulose interpolymers and method of oxidation
AU2005286771B2 (en) * 2004-09-17 2011-04-21 David M. Dixon Wound care dressing and method using same
KR20130060276A (ko) 2004-10-20 2013-06-07 에디컨인코포레이티드 의료 장치에 사용하기 위한 강화 흡수성 다층 직물 및 이의 제조방법
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
DK1809342T3 (en) 2004-10-20 2015-08-17 Ethicon Inc absorbable hemostat
EP1919959B1 (en) * 2005-09-02 2016-10-26 Hemcon Medical Technologies (IP) Limited A method for preparing polyanhydroglucuronic acid and/or salts thereof
JP4975996B2 (ja) * 2005-09-30 2012-07-11 東邦化学工業株式会社 カチオン変性ペクチン及び該物質を含む化粧料組成物
GB2444232A (en) 2006-11-30 2008-06-04 Ethicon Inc Wound dressing compositions comprising cell lysates
US20090074837A1 (en) * 2007-09-19 2009-03-19 Ut-Battelle, Llc Bioresorbable Calcium-Deficient Hydroxyapatite Hydrogel Composite
US9376648B2 (en) 2008-04-07 2016-06-28 The Procter & Gamble Company Foam manipulation compositions containing fine particles
JP2010284216A (ja) * 2009-06-09 2010-12-24 Hogi Medical:Kk カルボキシメチルセルロース構造体及びその製造方法
JP5818055B2 (ja) * 2010-03-17 2015-11-18 静岡県公立大学法人 トリアセチルセルロースブロック共重合体、その中間体、充填剤、および、界面活性剤
CA2831897C (en) * 2011-03-30 2017-07-25 Nippon Paper Industries Co., Ltd. Method for producing cellulose nanofibers
DE102011007528A1 (de) * 2011-04-15 2012-10-18 Aesculap Aktiengesellschaft Thixotrope Zusammensetzung, insbesondere zur postchirurgischen Adhäsionsprophylaxe
EP2720667A2 (en) * 2011-06-16 2014-04-23 Unilever PLC Aqueous gels
CN104945448B (zh) 2015-05-22 2018-06-19 上海绿谷制药有限公司 一种氧化型β-1,4-寡聚葡萄糖醛酸及其制备方法和用途
WO2017206131A1 (en) * 2016-06-02 2017-12-07 Gunze Limited Medical fiber structure and medical laminate
KR102294257B1 (ko) * 2019-04-30 2021-08-26 한양대학교 에리카산학협력단 바이오셀룰로오스-펩티드 복합체 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE360128C (de) * 1921-01-03 1922-09-29 Albert Reychler Dr Verfahren zur Herstellung von Staerkeloesungen
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US3598622A (en) * 1969-02-19 1971-08-10 Cpc International Inc Alkali treated starch compositions
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
CA2033046C (en) * 1990-01-12 1999-08-03 Lowell Saferstein Process for preparing a neutralized oxidized cellulose product and its method of use
CN1035803C (zh) * 1990-07-24 1997-09-10 中国化工进出口总公司 可溶性止血织物
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
JP3357996B2 (ja) * 1993-03-26 2002-12-16 ライオン株式会社 金属イオン封鎖性オリゴマー化合物の製造方法及びそのオリゴマー化合物を含む洗浄剤組成物
US5414079A (en) * 1993-08-03 1995-05-09 Biocontrol Incorporated Oxidized cellulose
DE4411681A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verfahren zur Herstellung niedermolekularer Polysaccharidether

Also Published As

Publication number Publication date
PT907664E (pt) 2000-12-29
PL189194B1 (pl) 2005-07-29
ES2148991T3 (es) 2000-10-16
PL330825A1 (en) 1999-06-07
GB2314840B (en) 2000-09-06
ATE195742T1 (de) 2000-09-15
EP0907664B1 (en) 2000-08-23
DE69702911D1 (de) 2000-09-28
AU3269397A (en) 1998-01-21
EP0907664A1 (en) 1999-04-14
CZ427498A3 (cs) 1999-05-12
DE69702911T2 (de) 2001-02-22
AU725296B2 (en) 2000-10-12
KR20000022286A (ko) 2000-04-25
GB2314840A (en) 1998-01-14
CZ294839B6 (cs) 2005-03-16
CA2258849A1 (en) 1998-01-08
JP2009102645A (ja) 2009-05-14
BR9710003A (pt) 2000-01-11
WO1998000446A1 (en) 1998-01-08
HUP9903404A3 (en) 2001-03-28
GB9613683D0 (en) 1996-08-28
HUP9903404A2 (hu) 2000-03-28
CA2258849C (en) 2008-01-22
JP4302187B2 (ja) 2009-07-22
JP5208707B2 (ja) 2013-06-12
JP2000514110A (ja) 2000-10-24

Similar Documents

Publication Publication Date Title
GR3034853T3 (en) Oxidized oligosaccharides
HK1022251A1 (en) Novel use of native gellan gum.
CA2248006A1 (en) Activated linkers and methods for making and purifying the same
FI954888A0 (fi) Selluloosaa sitova alue
AU5062199A (en) Suppository formulations comprising anionic polysaccharide
CA2258502A1 (en) Modified factor viii
DE69534778D1 (en) Cathepsin-02-protease
BR9808491A (pt) Compostos calcilìticos
WO1998004582A8 (en) Isolated peptides derived from mage-2
NO965142D0 (no) Betaarkdannende peptider og geler fremstilt av disse
ID17527A (id) Pengurangan penguapan polimer
DK1012186T3 (da) Keratinocyt-vækstfaktorer og anvendelser deraf
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
MX9504044A (es) Procedimiento para la obtencion de celulosa regenerada aminada.
AU3711597A (en) A novel galanin receptor
BG101787A (en) Aprotinine options having improved properties
WO1996016170A3 (en) Proteins involved in the regulation of cell-cell adhesion and uses thereof
DE69731575D1 (de) Verfahren zur Herstellung von sulfatierten Lactosamin-Oligosacchariden
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
BG102937A (en) Zona pelucida proteins as contraceptives
AU1569700A (en) Novel therapeutic application of low molecular weight heparin
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
DE69701943D1 (de) Zusammensetzungen auf Basis von ABS Polymerisat
SE9604439D0 (sv) New receptor